Koda-Kimble Seed Award Fuels 11 Innovative Projects

Koda-Kimble

Mary Anne Koda-Kimble, PharmD

Eleven innovative projects with the potential to further the mission of the UCSF School of Pharmacy in new ways will garner a financial boost from the 2025 Mary Anne Koda-Kimble Seed Award for Innovation.

The annual award program, which is administered by the Center for Collaborative Innovation (CCI), funds $100,000 worth of projects for which there is no ready or traditional source of funding. This is the first year the award was offered in two categories: individual projects and cross-departmental collaborations.

Guo

Su Guo, PhD

“We were pleased to receive a number of strong applications in research, education, AI, patient care and public service,” said CCI Director Su Guo. “The new collaborative innovation category provides an opportunity for people from different departments and disciplines to work together to make a greater impact.”

Mary Anne Koda-Kimble, PharmD, served as the school’s dean from 1998 to 2012 and supported new directions in science, education and patient care. The Seed Award for Innovation honors her legacy and was announced in 2012 with a $1 million endowment from the Joseph and Vera Long Foundation.

Collaborative Innovation Projects

 

Principal Investigator

Department

Proposal Title

Collaborators

Priyanka Bajaj

Bioengineering and Therapeutic Sciences

Structure-Guided Approach to Develop Therapeutic Strategies to Combat Biomolecular Condensate Formation of MET Oncofusions

Beth Winger, Clinical Pharmacy

Kyle Cromer

Bioengineering and Therapeutic Sciences

Deploying CRISR screens to enhance ex vivo red blood cell manufacturing

Brian Shy, Laboratory Medicine

Li Li

Pharmaceutical Chemistry

Mitigating Microglia Activation Induced by Hyperglycemic Stress in Diabetic Retinopathy

Ran Cao, Psychiatry

Thu Pham

Student

Financial Literacy Series for Graduate Students

Allison Wang, Associate Students of the Graduate Division, and Duncan D'Anne, Graduate Division

Mahendra Wagle

Bioengineering and Therapeutic Sciences

Discovery of New Anxiolytics Through High Content in Vivo Behavioral Screening

Matthew McCarroll, Pharmaceutical Chemistry

Individual Innovation Projects

 

Principal Investigator

Department

Proposal Title

Additional Collaborators

Jennifer Cocohoba

Clinical Pharmacy/California Poison Control System (CPCS)

Transforming Primary Care Through Expanded Pharmacy Services

Lisa Kroon, Clinical Pharmacy

Craig Ennis

Quantitative Biosciences Institute

Optimization of Genetic Engineering by Cas9 and Cas12a Through Mapping and Functional Characterization Protein-Protein Interactions

Nevan Krogan, QBI

John Gross

Pharmaceutical Chemistry

Mining the ReFrame Library to Unleash Innate Immunity Against Mpox

 

Bani Tamraz

Clinical Pharmacy/CPCS

Leveraging Artificial Intelligence to Assess the Impact of Pharmacogenomics-Guided Tacrolimus Dosing on Clinical Outcomes in Transplant Patients

Jim St. Clair, Health Universe

Arun Wiita

Bioengineering and Therapeutic Sciences

Unlocking the Therapeutic Potential of BioPROTACs via TORPEDO: Targeted Oncoprotein Removal Powered by Enveloped Delivery of BioPROTACs

 

Harry Wu

Pharmaceutical Chemistry

Chimeric Antigen Receptor Interactomics via Synapse-Specific Photocatalytic Proximity Labeling

Young-wook Jun and James Wells, Pharmaceutical Chemistry

 

Tags

Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Department of Clinical Pharmacy

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.